Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02860156 · ClinicalTrials.gov registry record
Characterizing HIV-related Diastolic Dysfunction
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 195
- Enrollment target
NCT02860156: Completed study, sponsored by Duke University.
NCT02860156 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 195 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02860156 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
Study Summary
This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, echocardiography to determine characteristics unique to this patient population.
Primary Outcome
Compare inflammation between HIV+/DD- and HIV+/DD+ subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2018-02-09 |
What the finished NCT02860156 record still lists
NCT02860156 is an observational study that tracks outcomes without assigning an intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02860156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02860156 about?
NCT02860156 is a clinical study titled "Characterizing HIV-related Diastolic Dysfunction". This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, ec...
What is the current status of trial NCT02860156?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2016-11-15. Estimated completion is 2018-02-09.
Who is sponsoring clinical trial NCT02860156?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI